Some patients benefit from a slower titration schedule, moving up in smaller increments every 2 weeks instead of weekly
Its mechanism is based on increasing the expression of neurotrophic factors such as BDNF (Brain-Derived Neurotrophic Factor), which translates into: DIHEXA was developed by scientists at Washington State University as a potential therapeutic agent, originally studied for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's
The maker of Ozempic is planning to investigate a phenomenon surrounding its drug's effect on users' desire to drink alcohol
Rexall Pharmacy Group Ltd
Full-text article Dimet-Wiley AL, Latham CM, Brightwell CR, et al
While many people use GLP-1 RAs without serious complications, it is increasingly evident that these medications are not risk-free